Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization

PloS One
Maroulio PertesiCharles Dumontet

Abstract

The MYD88 L265P is a recurrent somatic mutation in neoplastic cells from patients with Waldenström Macroglobulinemia (WM). We identified the MYD88 L265P mutation in three individuals from unrelated families, but its presence did not explain the disease segregation within these WM pedigrees. We observed the mutation in these three individuals at high allele fractions in DNA extracted from EBV-immortalized Lymphoblastoid cell lines established from peripheral blood (LCL), but at much lower allele fractions in DNA extracted directly from peripheral blood, suggesting that this mutation is present in a clonal cell subpopulation rather than of germ-line origin. Furthermore, we observed that the MYD88 L265P mutation is enriched in WM families, detected in 40.5% of patients with familial WM or MGUS (10/22 WM, 5/15 MGUS), compared to 3.5% of patients with familial MM or MGUS (0/72 MM, 4/41 MGUS) (p = 10-7). The mutant allele frequency increased with passages in vitro after immortalization with Epstein-Barr virus (EBV) consistent with the MYD88 L265P described gain-of-function proposed for this mutation. The MYD88 L265P mutation appears to be frequently present in circulating cells in patients with WM, and MGUS, and these cells are amena...Continue Reading

References

Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·E V WallsD H Crawford
Dec 17, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S P TreonC C Morton
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Dec 24, 2010·Nature·Vu N NgoLouis M Staudt
Mar 6, 2012·Nature Methods·Ben Langmead, Steven L Salzberg
Aug 31, 2012·The New England Journal of Medicine·Steven P TreonZachary R Hunter
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Jan 15, 2013·Current Protocols in Human Genetics·Ivan AdzhubeiShamil R Sunyaev
Mar 16, 2013·Clinical Lymphoma, Myeloma & Leukemia·Robert A KyleS Vincent Rajkumar
Jan 7, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Anne-Claire ToffartElisabeth Brambilla
Jan 22, 2014·Human Pathology·Yuil KimYoung Hyeh Ko
Jun 5, 2014·Bioinformatics·Ameet TalwalkarDavid Patterson
Jul 6, 2014·Applied Immunohistochemistry & Molecular Morphology : AIMM·Cristina JiménezRamón García-Sanz
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Oct 4, 2015·Nature·Peter H SudmantJan O Korbel

❮ Previous
Next ❯

Citations

Mar 5, 2016·Current Treatment Options in Oncology·Prashant KapoorStephen M Ansell

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
PCR
restriction digests
Illumina sequencing
Exome Sequencing
flow cytometry

Software Mentioned

Genome Analysis Tool Kit ( GATK )
AnnoVar
Bowtie 2
Primer
BWA
Illumina RTA
GATK Unified Genotyper
Bowtie

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2021 Meta ULC. All rights reserved